«These findings could
allow the pharma companies to open up large libraries of potent drug candidates earlier discarded due to solubility problems and try them again together with Upsalite,» says Maria Strømme, Professor at the Division of Nanotechnology and Functional Materials at Uppsala University.
Not exact matches
Jazz said in a filing that it did so in response to the overall takeover environment for
pharma companies and in light of a patent litigation settlement that
allows Hikma Pharmaceuticals to sell a generic version of Xyrem with Jazz receiving royalty payments on those sales.
GEN List Rental
allows you to target your message to the top
pharma companies, biotechs, and universities worldwide.
The technology is
allowing basic scientists and small
companies to generate impressive libraries of molecules, on a scale once reserved for big
pharma, and select from them the most useful compounds.
«This
allows the
company to experience the individual and the individual gets a taste to see what it's like in biotech or big
pharma.»